Article
[The circadian effects of antiglaucomatous drugs].
Journal francais d'ophtalmologie - 1 Sept 2004
Bron A
Abstract excerpt
PURPOSE: To collect data reflecting the current knowledge on the interactions of medical antiglaucomatous therapy and circadian variations. METHOD: Review of the available literature published on this topic in common electronic databases. RESULTS: The IOP-reducing effect of a molecule throughout the day depends on many parameters and still remains poorly investigated. It is well known that beta-blockers have a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
